Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia

Por Stray-Pedersen, A, Aaberge, I S, Früh, A, Abrahamsen, T G
Publicado em 2005

Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors

Por AABERGE, I S, STEINSVIK, T E, GROENG, E-C, LEIKVOLD, R-B, LØVIK, M
Publicado em 1996

SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.

Por Aaberge, I S, Michaelsen, T E, Rolstad, A K, Groeng, E C, Solberg, P, Løvik, M
Publicado em 1992

Human Opsonins Induced during Meningococcal Disease Recognize Outer Membrane Proteins PorA and PorB

Por Lehmann, A. K., Halstensen, A., Aaberge, I. S., Holst, J., Michaelsen, T. E., Sørnes, S., Wetzler, L. M., Guttormsen, H.-K.
Publicado em 1999

The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents

Por STRAY-PEDERSEN, A, JÓNSSON, T, HEIBERG, A, LINDMAN, C R, WIDING, E, AABERGE, I S, BORRESEN-DALE, A L, ABRAHAMSEN, T G
Publicado em 2004

Seroepidemiological Study after a Long-Distance Industrial Outbreak of Legionnaires' Disease

Por Wedege, E., Bergdal, T., Bolstad, K., Caugant, D. A., Efskind, J., Heier, H. E., Kanestrøm, A., Strand, B. H., Aaberge, I. S.
Publicado em 2009